Gilead Sciences Inc (GILD)
Financial leverage ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | US$ in thousands | 58,995,000 | 54,525,000 | 53,579,000 | 56,292,000 | 62,125,000 | 62,373,000 | 62,337,000 | 61,876,000 | 63,171,000 | 62,557,000 | 62,870,000 | 63,080,000 | 67,952,000 | 67,098,000 | 67,984,000 | 67,492,000 | 68,407,000 | 60,878,000 | 55,934,000 | 59,741,000 |
| Total stockholders’ equity | US$ in thousands | 19,330,000 | 18,474,000 | 18,281,000 | 17,539,000 | 22,749,000 | 22,242,000 | 21,094,000 | 20,939,000 | 21,209,000 | 21,057,000 | 20,236,000 | 19,915,000 | 21,064,000 | 21,471,000 | 19,710,000 | 18,964,000 | 18,221,000 | 17,471,000 | 18,142,000 | 22,179,000 |
| Financial leverage ratio | 3.05 | 2.95 | 2.93 | 3.21 | 2.73 | 2.80 | 2.96 | 2.96 | 2.98 | 2.97 | 3.11 | 3.17 | 3.23 | 3.13 | 3.45 | 3.56 | 3.75 | 3.48 | 3.08 | 2.69 |
December 31, 2024 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $58,995,000K ÷ $19,330,000K
= 3.05
The financial leverage ratio for Gilead Sciences Inc has shown some fluctuations between March 31, 2020, and December 31, 2024. Initially starting at 2.69 in March 2020, the ratio increased steadily to 3.75 by December 2020, indicating an increase in leverage or debt financing.
Subsequently, there were some fluctuations, with the ratio moving between 3.56 and 2.96 over the next few quarters. Notably, there was a significant decrease in the financial leverage ratio to 2.73 by December 31, 2023, suggesting a potential reduction in the company's reliance on debt.
However, the ratio rose again to 3.21 by March 31, 2024, indicating a resurgence in leverage. The ratio then fluctuated once more, hovering around 2.93 to 3.05 for the next few quarters.
Overall, Gilead Sciences Inc's financial leverage ratio has shown fluctuations over the period, reflecting changes in the company's capital structure and debt levels. Investors and analysts may need to closely monitor these ratios to assess the company's financial risk and solvency position.
Peer comparison
Dec 31, 2024